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A B S T R A C T
Background: Published studies have shown excellent success rates and also low rates of 
life-threatening complications with trans-catheter closure of patent ductus arteriosus 
(PDA). However, most studies to date have been conducted in developed nations and 
reports from developing countries such as Iran are lacking.
Objectives: To report our experience with trans-catheter closure of patent ductus 
arteriosus (PDA) and compare two devices and complications.
Patients and Methods: From 2007 to 2011, 72 consecutive PDA cases were prospectively 
enrolled. For PDAs ≤ 2 mm, the coiling method was employed whereas patients with 
PDA > 2 mm received Amplatzer duct occlusion (ADO). Success was defined as trivial 
residual shunt (< 1 mm) in the echocardiography performed 30 minutes after the 
procedure. After the procedure, the patients were admitted to the pediatric cardiology 
ward and observed for 72 hours during which the occurrence of major and minor 
complications was monitored. Major complications included cardiac arrest, displacement 
and/or embolization of the device and patient needing blood transfusion due to severe 
hemorrhage. Sampling was based on convenience method and the patients who had 
significant pulmonary artery hypertension were excluded from our study. Statistical 
analyses were done using SPSS software version 23 (IBM corp., New York, United States). 
Continuous variables are presented as mean ± standard deviation. The Mann-Whitney 
U test was used to compare the differences between two independent groups. Categorical 
variables were depicted as proportions and compared across the intervention groups, 
using Chi-square with Fisher’s exact text where appropriate. In all tests, a P value < 0.05 
was deemed necessary to reject the null hypothesis.
Results: With the coiling (n = 39) and Amplatzer methods (n = 33), successful closure was 
observed totally and recovered with no major complications. Frequent complications were 
benign arrhythmia (44.4%), and hemorrhage in 1 (1.4%) of the patients. Complication 
rate did not differ between the two techniques (P > 0.05).
Conclusions: Excellent and comparable success rates for both closure techniques were 
observed and no major complications were observed.
*Corresponding author: Azita Chegini, Blood Transfusion Research Center, 
High Institute for Research and Education in Transfusion Medicine, Tehran, 
Iran. P.O. Box: 14665-1157, Tel: +98-2188601501, 
E-mail: azita_chegini@yahoo.com.
1. Background
Patent ductus arteriosus (PDA) is an arterial structure 
that connects the upper portion of descending aorta to 
the pulmonary artery. During fetal period, patency of the 
ductus is essential in normal development of the fetus and 
its premature closure will result in right heart failure and 
subsequent hydrops fetalis (1). Immediately after birth, 
however, rapid increase in oxygen tension of the circulation 
due to functioning lungs forces the small muscle cells of 
the ductus to constrict (2). Within the next two to three 
weeks, advancement of fibrosis leads to lumen obliteration 
and a permanent anatomical closure of the ductus ensues 
(2). If this process fails to initiate or progress, then PDA is 
formed. PDA accounts for 5 - 10% of all congenital heart 
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diseases and is estimated to occur in approximately 1 in 
2000 live births (3, 4).
The natural history of PDA varies and is largely dependent 
on the size of the vessel lumen, degree of shunting, and 
pulmonary vascular resistance (1). In a patient with 
large PDA, if no corrective measure is taken, persistent 
patency of the lumen leads to left heart failure, pulmonary 
hypertension, and subsequently Eisenmenger’s syndrome 
(5, 6). In rare instances, the clinical picture might also 
be complicated by ductus aneurysm, endarteritis, aortic 
dissection, and laryngeal nerve impingement (7-10). For 
these reasons, a therapeutic closure of the PDA is often 
sought, preferably at an early age (11).
In the past two decades, trans-catheter techniques have 
become the standard of care in the treatment of PDA, 
supplanting surgical ligation of the ductus in the majority 
of cases. Owing to the significant technical advancements 
in the field of trans-catheter embolization, even large 
PDAs are now routinely closed by deployment of state-
of-the-art devices and surgery is reserved for very large 
PDA, PDA with a complex anatomy, preterm infants, or in 
patients with failed catheterization (1, 4). Coil occlusion and 
Amplatzer duct occlusion (ADO) are the two most common 
trans-catheter techniques used for PDA embolization with 
excellent success rates and limited complications reported 
by large series and randomized clinical trials (12-18). 
These patients need special anesthetic management which 
depends on physiological and pharmacological principles 
(19). Most studies to date have only enrolled patients from 
centers in developed countries, and reports from developing 
countries, and in particular the Middle East, are lacking. 
This is especially important since success rate of the 
procedure and also rate of complications largely depend 
on the experience of the interventional cardiologist and 
also the level of care offered by the facility before, during, 
and after the procedure.
2. Objectives
In the present study, in a prospective evaluation of patients 
with PDA, we report our experience in a university affiliated 
teaching hospital in Iran (Shahid Modarres Hospital). 
Additionally, we provide a comparison between the coiling 
and ADO techniques for use in treatment of patients with 
PDA.
3. Patients and Methods
From January 2007 to March 2011, transcatheter closure of 
PDA was attempted in 72 patients aged between 20 days and 
51 years. All patients had clinical and/or echocardiographic 
signs of PDA confirmed by thorough physical examination 
and imaging techniques. The patients who had significant 
pulmonary artery hypertension were excluded from our 
study. In this center, the selection of the device type was 
based on the PDA size. For PDAs² 2 mm coiling method 
was employed whereas patients with PDA larger than 2 mm 
were treated with the ADO technique. With this strategy, 
over the course of four years, 39 patients were treated with 
the coiling method and in the other 33 cases, ADO device 
was deployed. Prior to catheterization, written informed 
consent was obtained from legal guardian of all participants. 
The ethics committee of the university also approved the 
study protocol.
All procedures were performed while the patient was 
sedated, using the following protocol: midazolam 0.5 mg/
kg oral for premedication 30 minutes before entering the 
cath. lab, then midazolam 0.05 - 0.1 mg/kg, fentanyl 0.5 
µg/kg, propofol 1 - 2mg/kg, and ketamin 0.2 - 0.8 mg/
kg administered intravenously for induction, followed by 
propofol 25 - 75 µg/kg/min during the procedure. The 
coiling was performed using the retrograde approach 
as previously described (14, 19, 20). In summary, after 
anesthesia, and ascertainment of hemodynamic stability, 
an aortogram in the lateral and right anterior oblique views 
was performed to carefully delineate the shape and diameter 
of the ductus and Heparin was administrated by single bolus 
(50 - 100 units/kg in pediatrics and 250 - 500 units/kg in 
adults). In all closures, a single coil (pfm medical, Koln, 
Germany) was used so that it was at least two times wider 
than the narrowest PDA diameter depicted on aortography. 
After coil deployment, a repeat aortogram confirmed its 
proper positioning. The procedure for ADO deployment 
has been previously described at length (12, 16, 17, 20-22).
In brief, after proper anesthesia and confirmation of 
hemodynamic stability, an investigatory aortogram was 
performed as described earlier for the coiling method. 
Following the aortogram, a guide wire was placed in the 
descending aorta by using an end-hole catheter. A long 
sheath was then introduced over the guidewire in the 
descending aorta from an intravenous access. The ADO 
device (Lifetech Scientific Co., Shenzhen, China) size was 
chosen so that it was at least 2 mm larger than the narrowest 
diameter of the PDA, as depicted on aortogram. With the 
sheath already in place, the device was deployed to the 
descending aorta and firmly pulled against the orifice of the 
ductus while gently pulling back the delivery sheath. With 
the sheath still in place, an immediate repeat aortogram 
was performed to assess the placement of the device into its 
desired position and, if ascertained, the device was released 
by counterclockwise rotation of the delivery cable.
After the procedure, the patients were admitted to the 
pediatric cardiology ward and observed for 72 hours during 
which the occurrence of major and minor complications was 
monitored. Major complications included cardiac arrest, 
displacement and/or embolization of the device and patient 
needing blood transfusion due to severe hemorrhage. In 
the event any of the major complications occurred, the 
patient was immediately transferred to the intensive care 
unit. Minor complications comprised benign arrhythmia. 
No prophylactic antibiotic therapy was administered. If 
infection at the site of sheath insertion was suspected, 
Keflin (25 - 50 mg/kg) plus gentamycin 1 - 1.5 mg/kg was 
administered intravenously. After catheterization, dorsal 
pedis and tibialis posterior artery were palpated hourly. 
If an acute arterial injury was suspected, as evidence of 
weak or absent pedal pulse, unfractionated heparin was 
administrated (10 unit/kg/hour). In both methods, the 
success was defined as no evidence of shunt, or trivial 
residual shunt (< 1 mm) in the echocardiography performed 
30 minutes after the procedure. The patients were followed 
up by daily echocardiography in the first three days, and 
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then every six months after discharge. Statistical analyses 
were done using SPSS software, version 23 (IBM corp., 
New York, United States). Continuous variables are 
presented as mean ± standard deviation. Mann-Whitney 
U test was used to compare the differences between the two 
independent groups. Categorical variables are depicted as 
proportions and compared across intervention groups using 
Chi-square with Fisher’s exact text where appropriate. In 
all tests, a P value < 0.05 was deemed necessary to reject 
the null hypothesis.
4. Results
During the study period, a total of 72 catheter placements 
were performed in patients with PDA. Baseline demographic 
and clinical characteristics of enrolled patients are delineated 
in Table 1. Males comprised the majority of patients (n = 49, 
68.1%). In the ADO group, the number of male patients was 
lower than the females (45.8% vs. 54.2%), but the difference 
did not reach statistical significance (P = 0.090). Age of the 
participants ranged from 20 days to 51 years. The median 
age was 2 years [interquartile range (IQR) 1 - 6.5 years], 
and there was no statistically significant difference between 
the two groups (P value = 0.113). The median weight was 
13 kg [interquartile range (IQR) 9 - 21 kg] and again it was 
similar between the two groups. (P value = 0.123).
In the coiling method, treatment outcomes according to 
closure method and related complications are summarized 
in Table 2. Coiling was successful in 39 (100%) patients 
without major complication, device embolization and shunt. 
Minor complications occurred in 19(48.7%) patients, with 
the most common being arrhythmia (PSVT). We did not 
observe other minor complications including hemorrhage.
ADO device was successfully placed in all 33 patients 
although subsequent embolization was not observed in our 
patients. Similar to the coiling method, the most common 
benign complication was arrhythmia which was observed 
in 13 (39.4%) patients. Hemorrhage at the site of sheath 
insertion was observed in one patient (1.4% totally), but 
it was not severe enough to necessitate blood transfusion.
A comparison between the frequencies of complications 
with the two methods is presented in Table 2. The 
proportion of patients with no complications was 
comparable between the two groups. Moreover, regarding 
complications, although one patient undergoing ADO 
closure experienced hemorrhage, the difference did not 
reach statistical significance probably due to larger sheath 
insertion site. The frequencies of other complications were 
approximately similar between the two groups. With Chi-
Square test, we did not have any relation between device 
and complication variables. (P = 0.428) The most common 
complication was benign arrhythmia. 40 patients (55.6%) 
had not any complications. The Mann-Whitney U non-
parametric test was used to test for differences in age 
values by device. No significant differences were found 
in the mean age by devices (Figure 1).
5. Discussion
In the present study, an excellent success rate of 
100% was achieved irrespective of the closure method 
employed. Similar success rates have also been reported 
by other research groups for both coiling and ADO closure 
methods (12-18).
Coil method is an effective technique in closure of 
small size PDA (Patent Ductus Arteriosus) which is 
applicable for patients with different sizes. This easy 
and inexpensive closure technique had a higher rate of 
significant complications such as hemolysis, residual shunt, 
embolization and second catheterization in a moderate to 
large PDA (2.5 mm). In small children with PDA ≥ 2.5 
mm, the coil moves toward the pulmonary or peripheral 
systemic arteries and can close it, so its implementation 
is difficult and unsuitable. The multiple coils approach in 
large PDA has been shown to increase the risk of failure 
and left pulmonary stenosis. Although the Amplatzer 
Duct Occluder (ADO) implementation is easy and has a 
moderately small delivery sheath (6 - 8 Fr), and provides 
the opportunity for repositioning and high proportions 
of closure. The Amplatzer has been demonstrated very 
adaptable to ductal anatomical variations and can close 
from moderate to very large PDA with shorter fluoroscopy 
and procedural time (3.5 kg).
In one of the earliest efforts, Masura and colleagues 
used the ADO device in an anterograde manner to close 
moderate to large PDAs in 24 patients aged 0.4 to 48 years 
(16). Successful implantation was achieved in all but one 
patient, and no major complications were recorded (16). A 
large multi-center trial in the United States also yielded 
comparable results with the ADO method. Of the 428 
patients with PDA diameter ranging from 0.9 to 11.2 mm, 
98% success rate was reported (17).
Table 1. Distribution of Complications in 72 Patients by Gender
Gender
Complications                
Female Male
Without complication 14 (%35) 26 (65%)
With complication 9 (28.1%) 23 (71.9%)
Total 23 (31.9%) 49 (68.1%)
   
Table 2. Distribution of Complications in 72 Patients by Device
Device
Complications            
Coiling Device Amplatzer Device
Without complication 20 (51.3%) 20 (60.6%)
With complication 19 (48.7%) 13 (39.4%)
Total 39 (54.2%) 33 (45.8%)
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Our experiment did not lead to any life-threatening event. 
Mehta and colleagues reviewed the records of pediatric 
patients having undergone cardiac catheterization from 
1994 and 2006 in Toronto, Canada (21). There were 
records of 674 PDA closures, among which 37 (5.4%) 
complications were observed (21). It is worth noting that 
only three complications (8%) were considered as major 
and one (2.7%) resulted in death (21). Device embolization 
and subsequent bowel ischemia were cited as the cause of 
death in the aforementioned subject (21). Along the same 
lines, Bennett and colleagues provided an account of all 
complications occurring during a 9-year period in pediatric 
patients undergoing cardiac catheterization, in a center in 
Birmingham, United Kingdom (23). Overall, 572 cases of 
PDA/ASD occlusion were recorded and events including 
both major and minor complications occurred in 24 (4.2%) 
patients (23). According to their findings, PDA/ASD 
closure was associated with the lowest rate of complications 
probably due to the elective nature of the procedure and 
conserved heart function in the affected individuals 24. Pass 
and colleagues in their multi-center clinical trial of ADO in 
the United States reported major and total complications in 
2.3% and 7.1% of the patients, respectively (17). Only one 
case of death occurred in a 15-month old patient five months 
after successful implantation and overwhelming sepsis was 
identified as the cause (17). Moreover, two cases of device 
embolization occurred; one required open surgery, and in 
the other, the device was retrieved percutaneously (17). 
The most common minor complications were hematoma 
of the groin, and loss of peripheral pulses (17). Like these 
observations, we report that, compared with routine reports 
from developed countries, there were no significant higher 
rate of complications. These complications underscore 
the fact that multiple factors influence the outcomes of 
cardiac catheterization and reports from various centers 
with different levels of care and experience are needed to 
reach firm conclusions regarding the safety and feasibility 
of a specific procedure.
Wessel and colleagues have shown that by clear 
demarcation of the PDA anatomy prior to catheterization, 
the use of a sedation/anesthesia regimen tailored to the 
patient’s condition, and avoidance of systemic anti-
coagulation, it is possible to markedly reduce the incidence 
of complications in PDA closure (24). By implementing 
these measures, they were able to perform trans-catheter 
closure in 23 patients without facing major complications 
(24). Of note, in 19 patients (82.6%) the procedure was 
carried out in an outpatient setting and the patients were 
Figure 1. The Diagram Showing the Flow of Participants through Each Stage of Research
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discharged the same day, thereby significantly shortening 
the length of hospital stay (24).
In the present study, success rate and complications of 
the coiling and ADO closure methods were compared. 
In our sample of 72 patients, success rate, and also rates 
for minor complications were not comparable between 
the two methods. Santoro and colleagues compared coil 
occlusion method with Cook detachable coils with ADO 
device for large PDAs in 47 patients with an age range of 4 
months - 66 years (25). Congruent with our findings, they 
found that procedural success rate was comparable between 
the two methods (89.5% for coiling vs. 96.4% for ADO) 
(25). On the other hand, the coiling method was found 
to be significantly more time consuming, albeit cheaper 
(25). No major complications occurred in either group 
(25). In another study, Hunag and colleagues compared 
Gianturco multiple coiling with ADO occlusion for closure 
of large PDAs (19). According to their findings, although 
ADO yielded a better success rate immediately after the 
procedure and was less likely to fail, the 6-month success 
rates were comparable between the two techniques (100% 
for coiling vs. 94.5% for ADO) (19). Additionally, although 
device embolization and also hemolysis occurred more 
commonly among patients receiving coil occlusion, the 
difference was not statistically significant (19).
Conclusion: Excellent and comparable success rates 
for both closure techniques were observed with no major 
complications.
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